TRIBUTE study

GPTKB entity

Statements (64)
Predicate Object
gptkbp:instance_of gptkb:legal_case
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Trixeo_Aerosphere
gptkbp:aims_to efficacy of chemotherapy
optimal treatment duration
gptkbp:analysis patient responses
gptkbp:business_model institutional review board
gptkbp:collaborations academic institutions
healthcare providers
pharmaceutical companies
multinational study
gptkbp:collection adverse effects
gptkbp:conducted gptkb:various_countries
hospital settings
research teams
multidisciplinary teams
several years
patient consent
clinical guidelines.
multiple clinical sites
gptkbp:contributed_to oncology research
gptkbp:focuses_on gptkb:healthcare_organization
treatment protocols
improving patient outcomes
treatment advancements
https://www.w3.org/2000/01/rdf-schema#label TRIBUTE study
gptkbp:involves randomized controlled trial
gptkbp:is_analyzed_in statistical methods
treatment efficacy
treatment response
clinical effectiveness
gptkbp:is_compared_to different treatment protocols
gptkbp:is_designed_to improve treatment outcomes
adult patients
gptkbp:is_documented_in research publications
clinical trial registries
gptkbp:is_evaluated_by quality of life
long-term effects
independent reviewers
patient survival rates
safety and tolerability
gptkbp:is_monitored_by gptkb:data_safety_monitoring_board
gptkbp:is_part_of cancer research initiatives
global health initiatives
cancer clinical trials
clinical research network
larger research initiative
gptkbp:is_supported_by non-profit organizations
research institutions
gptkbp:led_to oncologists
gptkbp:measures survival rates
gptkbp:participants various demographics
patients with lung cancer
gptkbp:presented_by medical conferences
gptkbp:published_by peer-reviewed journals
medical journals
oncology journals
gptkbp:receives_funding_from government grants
gptkbp:registration clinicaltrials.gov
gptkbp:reports_to annual conferences
clinical trial reports
gptkbp:sponsor gptkb:healthcare_organization
gptkbp:uses chemotherapy regimens
gptkbp:utilizes placebo control